United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Endexx Corp? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| ROE | 45.61% | -83.2% | -80.36% | -87.11% | -93.71% | -94.31% |
|---|---|---|---|---|---|---|
| ROA | -64.96% | -4.16% | -4.02% | -4.36% | -4.69% | -4.72% |
| Gross Margin | 60.24% | 59.41% | 58.55% | 58.07% | 56.98% | 56.49% |
| Net Margin | -228.46% | -21.93% | -20.76% | -22.07% | -23.89% | -24.19% |
| Total Assets | $13,278.39K | $16,823.07K | $18,204.80K | $19,700.67K | $21,320.15K | $23,073.54K |
| Net Income | -$4,884.47K | -$673.27K | -$703.67K | -$825.46K | -$961.03K | -$1,046.65K |